Prime Medicine Inc (NASDAQ: PRME) is -31.51% lower on its value in year-to-date trading and has touched a low of $1.65 and a high of $8.27 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PRME stock was last observed hovering at around $1.76 in the last trading session, with the day’s gains setting it 0.24%.
Currently trading at $2.00, the stock is -12.06% and -23.56% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.95 million and changing 13.64% at the moment leaves the stock -49.24% off its SMA200. PRME registered -72.07% loss for a year compared to 6-month loss of -46.52%. The firm has a 50-day simple moving average (SMA 50) of $2.6165 and a 200-day simple moving average (SMA200) of $3.94005.
The stock witnessed a -33.11% gain in the last 1 month and extending the period to 3 months gives it a -30.56%, and is 4.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.45% over the week and 10.91% over the month.
Prime Medicine Inc (PRME) has around 214 employees, a market worth around $262.32M and $2.98M in sales. Profit margin for the company is -6566.61%. Distance from 52-week low is 21.21% and -75.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-102.92%).
with sales reaching $3.43M over the same period.The EPS is expected to grow by 27.26% this year, but quarterly earnings will post 560.21% year-over-year. Quarterly sales are estimated to grow 480.77% in year-over-year returns.
172.0 institutions hold shares in Prime Medicine Inc (PRME), with institutional investors hold 77.60% of the company’s shares. The shares outstanding are 131.16M, and float is at 51.92M with Short Float at 34.75%. Institutions hold 59.05% of the Float.
The top institutional shareholder in the company is ALPHABET INC. with over 15.06 million shares valued at $$77.42 million. The investor’s holdings represent 12.6375 of the PRME Shares outstanding. As of 2024-06-30, the second largest holder is ARK INVESTMENT MANAGEMENT LLC with 6.13 million shares valued at $$31.49 million to account for 5.1404 of the shares outstanding. The other top investors are T. ROWE PRICE INVESTMENT MANAGEMENT, INC. which holds 3.73 million shares representing 3.1259 and valued at over $$19.15 million, while SUMITOMO MITSUI TRUST HOLDINGS, INC. holds 2.717 of the shares totaling 3.24 million with a market value of $$16.65 million.
